PET-CT 스캐너 기기 시장 보고서 : 유형, 슬라이스 수, 아이소토프와 검출기 유형, 서비스 프로바이더, 용도, 지역별(2024-2032년)

The global PET-CT scanner device market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032. The market is experiencing stable growth driven by rising prevalence of cancer due to lifestyle changes and environmental factors, increasing technological innovations that are leading to enhanced imaging quality, efficiency, and patient safety, and the growing geriatric population.

PET-CT Scanner Device Market Analysis:

Market Growth and Size: The market is witnessing steady growth on account of the improving healthcare infrastructure, along with rising investments in advanced imaging technologies.

Technological Advancements: Integration of artificial intelligence (AI) algorithms and multimodal imaging capabilities is augmenting diagnostic capabilities and streamlining workflows.

Industry Applications: PET-CT scanner devices find applications in cardiovascular and neurological disorders.

Geographical Trends: Asia Pacific leads the market, driven by the rising number of new hospitals, diagnostic centers, and specialty clinics. However, North America is emerging as a fast-growing market due to the increasing awareness among individuals about the benefits of early diagnoses.

Competitive Landscape: Key players are investing in research and development (R&D) activities to develop innovative PET-CT scanner technologies with improved imaging capabilities, enhanced diagnostic accuracy, and patient comfort.

Challenges and Opportunities: While the market faces challenges, such as high initial costs, it also encounters opportunities on account of the expanding applications of PET-CT imaging.

Future Outlook: The future of the PET-CT scanner device market looks promising, with the evolving healthcare needs among individuals. Furthermore, the rising development of compact and portable PET-CT scanners will enable PoC imaging, which is anticipated to bolster the market growth.

PET-CT Scanner Device Market Trends:

Rising prevalence of cancer cases

The increasing prevalence of cancer among the masses around the world is propelling the PET-CT scanner device market growth. PET-CT scanners play a pivotal role in cancer diagnosis, staging, and treatment monitoring. Early detection through PET-CT imaging enhances treatment efficacy and patient outcomes, contributing to its widespread adoption. Moreover, healthcare providers are increasingly relying on PET-CT scans for accurate disease characterization and personalized treatment planning. These scans utilize radiopharmaceuticals that are selectively taken up by cancer cells, allowing for the visualization of metabolic activity within tumors. Meanwhile, CT scans provide detailed anatomical images that help precisely locate abnormal metabolic activity detected by PET. The comprehensive information obtained from PET-CT scans aids oncologists in making informed decisions regarding treatment strategies, including surgery, radiation therapy, chemotherapy, and targeted therapies. In addition, PET-CT scans enable prompt initiation of treatment and potentially improve patient outcomes. There is a rise in the need for improved access to advanced diagnostic tools to fight against cancer.

Technological advancements

Innovations in PET-CT scanners assist in enhancing imaging quality, efficiency, and patient safety. Modern PET-CT scanners feature higher spatial resolution that allows for clearer visualization of small lesions and improved accuracy in tumor detection and characterization. This advancement enables earlier diagnosis and more precise treatment planning. Moreover, advanced PET-CT scanners offer shorter scan times that benefit in reducing patient discomfort and enhancing workflow efficiency in healthcare settings. Rapid image acquisition enables clinicians to perform more scans in a time frame, leading to increased patient throughput and improved resource utilization. Furthermore, advancements in PET-CT technology are leading to the development of scanners with lower radiation doses while maintaining diagnostic image quality. These scanners improve safety and reduce the risk of long-term adverse effects associated with repeated imaging studies by minimizing radiation exposure to patients. Apart from this, PET-CT scanners employed with advanced motion correction techniques, such as respiratory gating and motion tracking, ensure sharper and artifact-free images.

Increasing geriatric population

The growing demand for PET-CT scanner devices due to rising geriatric population worldwide is positively influencing the market. Elderly individuals are more susceptible to cancer, Alzheimer's disease, cardiovascular disorders, and other chronic diseases, necessitating advanced devices that detect and monitor diseases accurately. PET-CT scanners enable comprehensive assessment of cardiac function, myocardial perfusion, and viability, aiding in the diagnosis and management of cardiovascular conditions in geriatric patients. Moreover, aging is associated with an increased risk of neurodegenerative disorders. PET-CT imaging provides valuable insights into brain metabolism, amyloid deposition, and neuroreceptor binding that facilitate early diagnosis and disease monitoring in elderly individuals. Apart from this, geriatric patients often have multiple comorbidities, requiring comprehensive diagnostic evaluations. PET-CT scanners offer multimodal imaging capabilities, allowing for simultaneous assessment of multiple organ systems in a single examination. This integrated approach benefits in streamlining diagnostic workflows and enhancing clinical decision-making in managing complex health conditions in the elderly.

PET-CT Scanner Device Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, slice count, isotope and detector type, service provider, and application.

Breakup by Type:

Stationary Scanners

Portable Scanners/Mobile Scanners

Stationary scanners account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes stationary scanners and portable scanners/mobile scanners. According to the report, stationary scanners represented the largest segment.

Breakup by Slice Count:

Low Slice Scanner (<64 Slices)

Medium Slice Scanner (64 Slices)

High Slice Scanner (>64 Slices)

Medium slice scanner (64 slices) holds the largest market share

A detailed breakup and analysis of the market based on the slice count have also been provided in the report. This includes low slice scanner (<64 slices), medium slice scanner (64 slices), and high slice scanner (>64 slices). According to the report, medium slice scanner (64 slices) accounted for the largest market share.

Breakup by Isotope and Detector Type:

Flurodeoxyglucose (FDG)

62Cu ATSM

18 F Sodium Fluoride

FMISO

Gallium

Thallium

Others

Flurodeoxyglucose (FDG) represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the isotope and detector type. This includes flurodeoxyglucose (FDG), 62Cu ATSM, 18 F sodium fluoride, FMISO, gallium, thallium, and others. According to the report, flurodeoxyglucose (FDG) represented the largest segment.

Breakup by Service Provider:

Hospitals

Diagnostic Centers

Research Institutes

Hospitals exhibit a clear dominance in the market

The report has provided a detailed breakup and analysis of the market based on the service provider. This includes hospitals, diagnostic centers, and research institutes. According to the report, hospitals represented the largest segment.

Breakup by Application:

Oncology

Neurology

Cardiology

Others

Oncology dominates the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, neurology, cardiology, and others. According to the report, oncology represented the largest segment.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Asia Pacific leads the market, accounting for the largest PET-CT scanner device market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share due to the presence of well-established new hospitals, diagnostic centers, and specialty clinics. In addition, the rising prevalence of cancer among individuals in the region is bolstering the market growth.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Bruker Corporation

Canon Medical Systems Usa Inc.

General Electric Company

Hitachi Ltd.

Koninklijke Philips N.V.

Mediso Ltd.

Neusoft Corporation

Positron Corporation

Shimadzu Corporation

Siemens Healthcare GmbH (Siemens AG)

Sofie Biosciences Inc.

United Imaging Healthcare Co. Ltd.

Yangzhou Kindsway Biotech Co. Ltd.

Key Questions Answered in This Report

• 1. What was the size of the global PET-CT scanner device market in 2023?
• 2. What is the expected growth rate of the global PET-CT scanner device market during 2024-2032?
• 3. What are the key factors driving the global PET-CT scanner device market?
• 4. What has been the impact of COVID-19 on the global PET-CT scanner device market?
• 5. What is the breakup of the global PET-CT scanner device market based on the type?
• 6. What is the breakup of the global PET-CT scanner device market based on the slice count?
• 7. What is the breakup of the global PET-CT scanner device market based on the isotope and detector type?
• 8. What is the breakup of the global PET-CT scanner device market based on the service provider?
• 9. What is the breakup of the global PET-CT scanner device market based on the application?
• 10. What are the key regions in the global PET-CT scanner device market?
• 11. Who are the key players/companies in the global PET-CT scanner device market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global PET-CT Scanner Device Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Stationary Scanners
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Portable Scanners/Mobile Scanners
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Slice Count

• 7.1 Low Slice Scanner (<64 Slices)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Medium Slice Scanner (64 Slices)
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 High Slice Scanner (>64 Slices)
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Isotope and Detector Type

• 8.1 Flurodeoxyglucose (FDG)
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 62Cu ATSM
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 18 F Sodium Fluoride
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 FMISO
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Gallium
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Thallium
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast
• 8.7 Others
  • 8.7.1 Market Trends
  • 8.7.2 Market Forecast

9 Market Breakup by Service Provider

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Diagnostic Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Research Institutes
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Application

• 10.1 Oncology
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Neurology
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Cardiology
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Others
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia-Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 Bruker Corporation
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
    • 16.3.1.3 Financials
    • 16.3.1.4 SWOT Analysis
  • 16.3.2 Canon Medical Systems Usa Inc.
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
  • 16.3.3 General Electric Company
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
    • 16.3.3.3 Financials
    • 16.3.3.4 SWOT Analysis
  • 16.3.4 Hitachi Ltd.
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
    • 16.3.4.3 Financials
    • 16.3.4.4 SWOT Analysis
  • 16.3.5 Koninklijke Philips N.V.
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Mediso Ltd.
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
  • 16.3.7 Neusoft Corporation
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
    • 16.3.7.3 Financials
    • 16.3.7.4 SWOT Analysis
  • 16.3.8 Positron Corporation
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
    • 16.3.8.3 Financials
  • 16.3.9 Shimadzu Corporation
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
    • 16.3.9.3 Financials
    • 16.3.9.4 SWOT Analysis
  • 16.3.10 Siemens Healthcare GmbH (Siemens AG)
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
    • 16.3.10.4 SWOT Analysis
  • 16.3.11 Sofie Biosciences Inc.
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
  • 16.3.12 United Imaging Healthcare Co. Ltd.
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio
  • 16.3.13 Yangzhou Kindsway Biotech Co. Ltd.
    • 16.3.13.1 Company Overview
    • 16.3.13.2 Product Portfolio